Thymosin Alpha-1

Half-life context

Unknown. No verified formulation-specific human estimate in this source set; no guessed value is supplied.

Regulatory status

Checked 2026-10-09

FDA product approval

not approved. No US therapeutic product approval is established by this curated source set; other countries and products may differ.

Compounding

not established. Compounded products do not carry FDA product approval; legal eligibility is not established here.

Research status

investigational. Evidence varies by illness and country; general immune or longevity benefit is not established.

Sport status

unknown. Not individually verified; consult the current sport rules. Absence of a listing is not permission.

Evidence C

Limited or early human observations; substantial uncertainty remains.

Grades describe the cited population and indication, not safety or suitability for an individual.

Population: Evidence varies by illness and country; general immune or longevity benefit is not established.

Indication: No general wellness indication established.

Basis: Limited or preclinical evidence; the grade is not a safety rating.

Risks

• Safety is incomplete; absence of reports does not establish safety.

Contraindications

• Unknown or incomplete for research formulations; this is not a clearance for use.

Interactions

• Unknown or incomplete; do not infer compatibility with medications or other substances.

What to record

• Existing clinician-directed records, symptoms and dated health measurements.
• Record missing data; trends do not demonstrate causation.

A licensed clinician must interpret the evidence for your situation. This entry provides education, not treatment instructions.

Review: source-curated; clinician review pending

Sources

• Primary evidence or regulator source. Checked 2026-10-09